A CSF-based study showed that lactate levels in patients with PD (n = 101) increased compared with controls (n = 60) and were correlated with both clinical disease progression and neurodegeneration biomarkers, such as tau proteins and dopamine [60]. This evidence concerns the gene MAPT and Parkinson disease.